Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
24 hedge funds and large institutions have $218K invested in Celgene Corporation Contingent Value Rights in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
20% more funds holding
Funds holding: 20 → 24 (+4)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
37% less capital invested
Capital invested by funds: $344K → $218K (-$126K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$16.7K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$12K |
| 3 |
TPA
Trivium Point Advisory
Westport,
Connecticut
|
+$5.57K |
| 4 |
DAM
Deltec Asset Management
New York
|
+$5.48K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
-$62K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$47K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$31.4K |
| 4 |
Koshinski Asset Management
Decatur,
Illinois
|
-$10K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.12K |
CELGZ Hedge Fund Activity: Q3 2019 in Review
24 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q3 2019, worth a combined $218K — down 37% from $344K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CELGZ positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $16.7K. The largest seller was Cannell & Co, exiting entirely with an estimated $62K sold.
- 24 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q3 2019, up from 20 in Q2 2019.
- Funds reported $218K of Celgene Corporation Contingent Value Rights stock for Q3 2019, down 37% quarter-over-quarter.
- 7 funds opened new Celgene Corporation Contingent Value Rights positions in Q3 2019 and 3 closed out, a net change of +4 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q3 2019 was Private Advisor Group, an estimated $16.7K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q3 2019 was Cannell & Co, an estimated $62K sold.
Based on aggregated 13F filings for Q3 2019.